US · USD
KNSA
Kiniksa Pharmaceuticals Ltd
- Day's range
- $74.70 – $79.22
- Day's volume
- $16.8M
- 52-week range
- $37.01 – $80.92
Follow KNSA in the Fuolio
See how KNSA weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountKNSA in numbers
- Dividend yield (12m)
- 0.00%
KNSA price history
KNSA risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +82.08% | +378.79% | +566.27% |
| Volatility (annualized) | 38.35% | 40.07% | 48.02% |
| Largest drawdown | -10.04% | -26.70% | -36.13% |
| Positive months | 9/12 | 24/36 | 35/60 |
How much did investing in KNSA return?
$1,000.00 invested on 11/01/2021 would be worth $6,662.65 today.
- Value today in KNSA
- $6,662.65
- Return over the period
- +566.27%
- Return per year
- +46.91%
- In the S&P 500
- $1,707.20
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
KNSA fundamentals
Debt
- Net debt—
- Net debt/EBITDA—
- Net debt/Equity—
- Debt/Equity—
- Current ratio3.79
- Quick ratio3.33
- Cash ratio2.99
Efficiency
- Gross margin89.31%
- EBITDA margin12.58%
- Operating margin12.36%
- Net margin9.69%
- Asset turnover0.91
Profitability
- ROE12.06%
- ROA8.85%
- ROIC10.61%
- Payout—
KNSA's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| ROE | 10.40% | -9.85% | 3.21% | 46.29% | -85.35% | -51.74% | -71.81% | -36.96% |
| ROIC | 9.03% | -10.40% | -0.00% | 2.47% | -84.65% | -50.45% | -74.46% | -38.65% |
| Gross margin | 88.54% | 85.61% | 87.64% | 89.60% | 76.39% | — | — | — |
| EBITDA margin | 11.63% | -10.38% | -8.46% | 5.53% | -400.27% | — | — | — |
| Net margin | 8.71% | -10.21% | 5.21% | 83.28% | -409.72% | — | — | — |
KNSA's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $677.6M | $423.2M | $270.3M | $220.2M | $38.5M | — |
| Cost of revenue | -$77.7M | -$60.9M | -$33.4M | -$22.9M | -$9.1M | — |
| Gross profit | $599.9M | $362.3M | $236.9M | $197.3M | $29.4M | — |
| EBITDA | $78.8M | -$43.9M | -$22.9M | $12.2M | -$154.3M | -$155M |
| EBIT | $77.2M | -$45.6M | -$25.2M | $9.8M | -$156.6M | -$157.4M |
| Financial result | — | — | — | — | — | — |
| Income before tax | $88.9M | -$36.2M | -$16.7M | $11M | -$156.5M | -$156.2M |
| Income tax | -$29.9M | -$7M | $30.7M | $172.3M | -$1.4M | -$5.2M |
| Net income | $59M | -$43.2M | $14.1M | $183.4M | -$157.9M | -$161.4M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does KNSA pay dividends?
KNSA has no distributions on record.
About Pharmaceuticals Ltd
- Sector
- Manufacturing
Questions about KNSA
How much is KNSA today?
KNSA is at $77.42 (0.43% on the day), last traded on 10/07/2026.
How much did KNSA return in 12 months?
KNSA returned 82.08% in 12 months, with annualized volatility of 38.35% and a largest drawdown of -10.04%.